BOCA RATON, Fla., Feb. 27, 2017 /PRNewswire/ — Cancer Treatment Centers of America® (CTCA), in collaboration with NantHealth and Allscripts, is implementing a custom technical solution that, for the first time, enables eviti®, a NantHealth clinical decision support solution, access to clinical workflows in the Allscripts Sunrise electronic health record (EHR). With seamless integration of this clinical decision support solution, the Clinical Pathways program helps inform the cancer treatment process, without interrupting the physician’s clinical workflow. The direct interface of the clinical operating system (NantOS) was built with the input of hundreds of oncologists across the nation and holds a comprehensive collection of evolving cancer care data.

«Clinical Pathways presents all appropriate treatment options. It also helps eliminate potential guesswork by clinicians routinely inundated with new data and oncology research,» said George Daneker, Jr., MD, Chief Medical Officer at CTCA® at Southeastern Regional Medical Center. «We created an ecosystem of treatment options, customized to the CTCA standard of care, for patients to review and choose from that’s safe and efficient.»

Designed with the patient in mind, Clinical Pathways integrates the latest cancer research available, treatment regimens and complementary therapies into the Allscripts Sunrise EHR, giving oncologists the ability to create a curated list of care protocols at the point of care. When the treatment platform is engaged it provides:

  • Custom treatment regimens specific to the patient, their health and specific disease state
  • Comparisons between treatment options, including average market cost of delivery
  • Computer order entry with the tap of the screen – safe for the patient and efficient
  • Each treatment regimen recommended by eviti is mapped within the EHR to proprietary CTCA order sets that reflect  an integrative approach to care delivery, which combines evidence-based clinical approaches with supportive therapies to meet each patient’s unique needs and optimize their quality of life while undergoing cancer treatment
  • Access to referenced up-to-date guidelines, response rates, adverse drug reactions and toxicity
  • Supporting clinical data
  • Real-time functionality

Clinical Pathways creates greater transparency around therapeu­tic selection and care delivery, and also helps to improve qual­ity and efficiency by reducing variability in care. With this integrated platform, patients and their clinical teams can discuss and compare treatment regimens, providing patients with greater confidence of the appropriateness of their prescribed treatment for their specific diagnosis. Clinical Pathways can also expedite approval from insurance providers by effectively providing the necessary clinical data to support selected treatment strategies. 

«Cancer Treatment Centers of America, Allscripts and NantHealth began planning this project in early 2016 to help patients and providers alike benefit from the clinical capabilities of an integrated solution,» said Paul Black, Allscripts Chief Executive Officer. «Through a careful analysis of clinical workflows and strategic design sessions, we’ve delivered a solution that enhances and improves the chemotherapy regimen selection and ordering process, and ultimately, the quality of care CTCA provides to its patients.»

The integration of the eviti solution with Allscripts Sunrise EHR for Clinical Pathways allows physicians to retrieve information from an unbiased Evidence-Based Medical Library, which encompasses over 2,700 of the most appropriate, evidence-based treatment regimens covering all cancers and cancer subtypes and all modalities. The library is meticulously compiled from peer-reviewed literature, oncology associations, and government agencies, and maintained by a full-time team of oncologists and oncology nurses, clinical informatics professionals, and an advisory board of nationally recognized oncology experts. Each regimen incorporates the level of evidence, expected clinical outcomes, treatment costs, toxicities and supporting literature. Once a regimen is selected, providers can launch directly into order entry through Allscripts’ unique open ability to integrate eviti regimens with Sunrise order sets.

«The eviti solution plays an integral role in bringing together the Clinical Pathways platform by allowing physicians access to real-time evidence-based treatment regimens for all types of cancer,» said Bobby Reddy, Senior Executive Director of Medical Affairs of NantHealth. «The collective technology is proving to be a game changer for cancer care – allowing communication with all key stakeholders to occur more efficiently from prognosis to diagnosis to treatment. We’re pleased to support CTCA’s Clinical Pathways platform with NantHealth’s eviti solution to advance cancer care and treatment.»

Clinical Pathways is available for use with every patient at all five CTCA hospital locations.

About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit, and

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth’s unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. For more information please visit and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.

About eviti®
eviti® is a SaaS-based, point-of-care clinical decision support platform that allows oncologists to quickly see and assess treatment regimens, outcomes, cost, and level of evidence in order to confidently select a clinically-appropriate treatment. eviti consists of three applications – eviti Advisor, eviti Advisor Enterprise, and eviti Connect® – that together support advanced cancer care by aligning the priorities of physicians, payors, and patients at the moment of clinical prescribing.

Abigail Obre
[email protected]  
(561) 923-3198 (O)
(954) 551-0519 (C)


To view the original version on PR Newswire, visit:

SOURCE Cancer Treatment Centers of America